Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia-Reference-Cited by-同舟云学术

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

Published:2022-04-21 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Malama Kalonde¹,Tichacek Amanda²,Kelly Hilary³,Parker Rachel²,Inambao Mubiana⁴,Sharkey Tyronza¹,Wall Kristin M.²⁵,Kilembe William¹,Price Matt A.⁶⁷,Fast Pat⁶,Priddy Fran⁶,Allen Susan²

Affiliation:

1. Center for Family Health Research in Zambia, Rwanda Zambia HIV Research Group, Lusaka, Zambia

2. Rwanda Zambia HIV Research Group, Emory University, School of Medicine, Atlanta, GA, USA

3. Centers for Disease Control and Prevention, Atlanta, GA, USA

4. Center for Family Health Research in Zambia, Rwanda Zambia HIV Research Group, Ndola, Zambia

5. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA

6. IAVI, New York, NY, USA

7. Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA

Funder

International AIDS Vaccine Initiative (IAVI) with the generous support of the American

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2066426

Reference18 articles.

1. Measles – The epidemiology of elimination

2. Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa

3. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey